Cover -- Title Page -- Copyright Page -- Preface -- The Editor -- Associate Editor -- Dedication -- Contributors -- Table of Contents -- Chapter 1 Cellular Immunotherapy of Cancer: Preclinical and Clinical Testing UtilizingInter leukin-2 -- Chapter 2 Long-Term Culture of IL-2 Generated Killer Cells with Antitumor Activity -- Chapter 3 Function of Interleukin-2 Activated NK Cells in Leukemia Resistance and Treatment -- Chapter 4 Utilizing Lymphokine-Activated Killer Cells for Bone Marrow Purging -- Chapter 5 Cell-Mediated Cytotoxicity Against Fresh Solid Tumor Cells: Regulation by Soluble Mediators -- Chapter 6 Down-Regulation of Human Bone Marrow Cells and Their Progenitors by IL-2-Activated Lymphocytes -- Chapter 7 IL-2-Induced Cytotoxic Cells from Human Thymocytes -- Chapter 8 Regulation of NK Cytotoxicity In Vivo in Patients Receiving IL-2 -- Chapter 9 Synergism between Cyclophosphamide and Interleukin-2 -- Chapter 10 Human Tumor-Infiltrating Lymphocytes and Their Characterization -- Chapter 11 Growth Kinetics, Function, and Characterization of Lymphocytes Infiltrating Ovarian Tumors -- Chapter 12 Cancer Treatment Using IL-2-Activated Killer Cells and/or IL-2 in Combination with Chemotherapeutic Drugs -- Chapter 13 Development of Adoptive Immunotherapy with In Vitro Sensitized T Lymphocytes from Mice Bearing Progressively Growing Tumors -- Chapter 14 Adoptive Transfer of T Cells for Therapy of Disseminated Leukemia: Antigen Specificity and Function of Tumor-Reactive T Cells -- Chapter 15 LAK Cells and Autologous Bone Marrow Transplantation: Toward a Cure for Leukemia -- Chapter 16 Tumor Inhibitory Effects of Regional Interleukin-2 Administration and the Role of Lymphokine-Activated Killer Cells -- Chapter 17 Tissue Distribution and Localization of IL-2-Activated Killer Cells after Adoptive Transfer In Vivo